Dr Tillotson's Churchill Fellowship builds on previous research on eScent® wearable technology and explored the early detection and management of individuals suffering with mental ill-health. Using aroma-based stress management strategies, Tillotson travelled to the USA in 2014 and found that anxiety, stress and the risk of an acute bipolar disorder episode could be reduced.  Now in the development stage, eScent® presents an empowering and enabling platform technology that emits timely, context-dependent mood-enhancing aromas working on biofeedback.